FUS Neuromodulation for Binge Eating Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of FUS neuromodulation in patients with Binge Eating Disorder (BED)
Who Is on the Research Team?
Ali Rezai
Principal Investigator
WVU Rockefeller Neuroscience Institute
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with Binge Eating Disorder who are interested in trying a new, non-invasive brain treatment. Specific inclusion and exclusion criteria are not listed, but participants must meet the diagnosis of BED.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- LIFU Neuromodulation
Trial Overview
The study is testing the safety and tolerability of LIFU (Low-Intensity Focused Ultrasound) neuromodulation—a non-surgical brain stimulation technique—in people with Binge Eating Disorder. All participants receive this treatment.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ali Rezai
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.